DEFINITY® News and Updates

Read More

The DEFINITY® Illuminate Series

See VALUE in

High DEF(INITY)™

The DEFINITY® Illuminate Series is designed to increase quality and efficiency, reduce costs, enhance diagnostic accuracy, and improve adherence to UEA guidelines1-4

Through the DEFINITY® Illuminate Series, Lantheus provides you with institutional and educational value presentations, webinars, and an operational efficiencies toolkit. They aim to:

  • Drive clinical and diagnostic value across stakeholders
  • Deliver clinical and technical support
  • Support the efficient implementation of DEFINITY® across clinical settings
  • Optimize DEFINITY® images
  • Help to integrate UEA policy
  • Help echo lab with sonographer administration of DEFINITY®
CLINICAL SPECIALIST PROGRAMS

clinical specialist programs

See SUPPORT in High DEF(INITY)™

Dedicated on-site clinical and technical support delivered by expert sonographers to assist with the efficient implementation of DEFINITY®.*

SPEAKERS PROGRAMS

Speaker Programs

See EXPERTISE in High DEF(INITY)™

Physicians and sonographers share their knowledge and experience on the diagnostic and clinical impact of DEFINITY® on echocardiograms in speaker program presentations.* 

NURSE PROGRAMS

Nurse Programs

See CARING in High DEF(INITY)™

Presentations that address nursing staff needs on the safety and efficacy of DEFINITY® and the overall impact it has on patient care.

  • These programs fulfill a need for structured teaching opportunities for non-reading clinicians, which benefits both patient care and interspecialty collaboration5
PHYSICIAN ROUNDTABLES

Physician Roundtable

See CONNECTIONS in High DEF(INITY)™

Physician-to-physician forums where HCPs can connect and share how UEAs impact the diagnostic capability of echocardiography.

IMPROVE PROGRAM

Improve Program

See IMPACT in High DEF(INITY)™

Designed to enhance echocardiography by identifying suboptimal echo rates and to illustrate the clinical and economic benefits that can be achieved with appropriate use of DEFINITY®. This quality improvement program helps participants:

  • Define and quantify the challenge and impact of suboptimal echo
  • Recognize the important role that DEFINITY® has in improving diagnostic quality, cardiac diagnosis, and patient management2,3
  • Identify costs of using DEFINITY® for patients with suboptimal echoes compared to the cost of other imaging modalities and related expenses associated with the need for additional downstream diagnostic procedures2,3
  • Evaluate the clinical and economic benefits that are possible with the appropriate use of DEFINITY®2-4
  • Initiate a quality echo program that will better serve their patients and their institution
INFORMATIONAL WEBINARS

Informational Webinars

See KNOWLEDGE in High DEF(INITY)™

Live and on-demand webinars designed to provide timely and important information on the use, implementation, and impact DEFINITY® has on cardiac diagnosis, patient management, and cost-effectiveness in echocardiography.* Topics include:

  • Cardiac diagnosis and patient management
  • Case study review
  • Contrast echo in critical care
  • DEFINITY® across multiple care settings
  • DEFINITY® implementation and administration
  • DEFINITY® safety profile
  • Guidelines and standards
  • Image optimization
  • Improving patient outcomes
  • Optimizing the value of DEFINITY®
  • Quality-driven echocardiography
  • Workflow efficiency
OPERATIONAL TOOL KIT

Operational Tool kit

See GUIDANCE in High DEF(INITY)™

A detailed guide to help implement DEFINITY® in your institution, including a summary of American Society of Echocardiography (ASE) Guidelines, discussion framework for roles and responsibilities for optimizing DEFINITY® use, and detailed instructions and troubleshooting tools.

* Society of Diagnostic Medical Sonography (SDMS) credits are available for sonographers who enroll in these programs.

American Association of Critical-Care Nurses (AACN) credits are available for nurses who enroll in these programs.

UEA=ultrasound enhancing agent

Annually, Lantheus educates ~10,000 HCPs through >1000 programs. A majority of the programs provide SDMS and AACN credits.1

References:

  1. Data on file, Lantheus.

  2. Kurt M, Shaikh KA, Peterson L, et al. Impact of contrast echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort. J Am Coll Cardiol. 2009;53(9):802-810. doi:10.1016/j.jacc.2009.01.005

  3. Main ML, Fu JW, Gundrum J, LaPointe NA, Gillam LD, Mulvagh SL. Impact of contrast echocardiography on outcomes in critically ill patients. Am J Cardiol. 2021;150:117-122. doi:10.1016/j.amjcard.2021.03.039

  4. Lester SJ, Askew JW, Hurst RT, et al. Contrast echocardiography: experience in a clinical echocardiography laboratory. J Am Soc Echocardiogr. 2006;19(7):919-923. doi:10.1016/j.echo.2006.01.025

  5. Ayesa SL, Katelaris AG, Brennan PC, Grieve SM. Medical imaging education opportunities for junior doctors and non-radiologist clinicians: a review. J Med Imaging Radiat Oncol. 2021;65(6):710-718. doi:10.1111/1754-9485.13266

INDICATIONS

DEFINITY® is indicated, after activation, for use in adult and pediatric patients with suboptimal echocardiograms to opacify the left ventricular chamber and to improve the delineation of the left ventricular endocardial border.

IMPORTANT SAFETY INFORMATION

WARNING: SERIOUS CARDIOPULMONARY REACTIONS

Serious cardiopulmonary reactions, including fatalities, have occurred uncommonly during or following perflutren-containing microsphere administration. Most serious reactions occur within 30 minutes of administration.

  • Assess all patients for the presence of any condition that precludes DEFINITY® administration [see Contraindications (4)].
  • Always have resuscitation equipment and trained personnel readily available [see Warnings and Precautions (5.1)].